Bell Asset Management posts strong growth



Bias towards small and mic cap companies which offer strong growth opportunity has helped Bell Asset Management (BAM) double its funds under management (FUM) in 18 months and record strong growth returns.
According to FE Analytics, the BAM Bell Global Emerging Companies fund had annualised one year returns of 16.50 per cent ahead of the benchmark (13.31 per cent) and far above the 7.85 per cent average of its returns over three years.
BAM FUM also rose to $1.5 billion with growth experienced in both Australia and the US.
Managing director, strategy and distribution Rob Sullivan, said: “We remained focussed on the areas where we see the most growth potential and have made a number of key changes to open up access.”
“We invested in distribution to further support and grow our client base,”
BAM’s flagship fund, Bell Global Equity Fund was added to the HUB24, Netwealth, OneVue and Macquarie Wrap platforms this year, and along with the Emerging Companies fund, is no longer exclusive to institutional investors.
“There is a growing demand from Australian retail investors, including those with self-managed superannuation funds, for access to high quality international funds,” Sullivan said.
FE Analytics showed the Bell Global Equity Fund had first quartile annualised one, three, five and 10 year returns at 19.29 per cent, 11.25 per cent, 17.81 per cent, and 5.02 per cent respectively.
Recommended for you
First Sentier Investors chief executive, Mark Steinberg, is set to depart the asset manager after seven years.
Metrics Credit Partners has completed the acquisition of Taurus Finance Group and BC Investment Group as it looks to launch consumer lending arm Navalo.
AMP has announced to the ASX that it is being sued by property fund manager Dexus regarding the sale of its real estate and domestic infrastructure equity business.
Having seen inflows of US$5.6 billion to its fixed income funds in the last quarter, Janus Henderson has closed on a deal with life insurer Guardian to secure funds to boost its product development.